NUC-7738
Advanced solid tumors, PD-1-Resistant Melanoma
Phase 1/2Active
Key Facts
About NuCana
NuCana is a UK-based, publicly traded biopharma company focused on transforming widely prescribed chemotherapy agents using its phosphoramidate-based ProTide technology. Its mission is to significantly improve survival outcomes for cancer patients by developing more effective and safer medicines. The company has a clinical-stage pipeline targeting various solid tumors and hematological malignancies, and is led by a management team with extensive drug development and commercialization expertise.
View full company profile